Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|August 18, 2025
Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomasKatherine E Lake, Meredith Jackson, Samantha Hull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain MetastasisKimberly L Johung, Norman Yeh, Neil B Desai, et al.
Advances in Radiation Oncology|September 22, 2025
Extracranial Palliative Radiation Therapy for Renal Cell CarcinomaYoung Suk Kwon, Eric Hsu, Maggie Stein, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2025
Adaptive Radiation Therapy in Lymphomas: Indications, Early Experiences, and Future DirectionsKiran A Kumar, Xinran Zhong, Zohaib Iqbal, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2021
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation TrialRaquibul Hannan, Samer Salamekh, Neil B Desai, et al.
Cancer|August 2, 2016
Genomic characterization of response to chemoradiation in urothelial bladder cancerNeil B Desai, Sasinya N Scott, Emily C Zabor, et al.
European Urology|January 8, 2018
Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall SurvivalWilliam C Jackson, Krithika Suresh, Vasu Tumati, et al.
Pageof 6